适应不良性紧急粒细胞生成预测失代偿期肝硬化住院患者不良结局
本研究对1260例无慢加急性肝衰竭(ACLF)的急性失代偿期肝硬化(ADC)患者入院时全血RNA测序数据进行分析,发现124例(9.8%)在28天内发展为ACLF。这些pre-ACLF患者表现出适应不良性紧急粒细胞生成(EG)特征,包括中性粒细胞增多、STAT3及其下游CEBPB上调、未成熟和成熟中性粒细胞相关基因上调、循环IL-6升高,以及低密度中性粒细胞和粒细胞型髓源性抑制细胞相关基因上调。基线适应不良性EG与ACLF发展风险独立相关,且pre-ACLF患者住院期间新发感染比例更高。
要点
- 入院时全血转录组显示适应不良性紧急粒细胞生成特征可预测28天内ACLF发展。
- pre-ACLF患者STAT3-CEBPB轴激活、IL-6升高及免疫抑制相关基因上调。
- 中性粒细胞分化与免疫抑制模块及循环细胞模块的eigengene升高与ACLF风险独立相关。
核心结论
- 无ACLF的ADC患者入院时全血转录组可揭示适应不良性EG激活,其后28天内发展为ACLF的风险增高。
- 适应不良性EG特征与住院期间新发感染增加及90天死亡风险增高相关。
研究设计与样本
- 对1260例无ACLF的急性失代偿期肝硬化(ADC)患者入院时(基线)全血RNA测序数据进行分析。
- 主要结局为第28天时ACLF发展;采用加权基因共表达网络分析(WGCNA)识别基因模块及其eigengene。
主要发现
- 124例(9.8%)患者在第28天发展为ACLF,被视为入院时pre-ACLF。
- pre-ACLF患者表现出中性粒细胞增多、STAT3及其下游CEBPB上调、未成熟和成熟中性粒细胞相关基因上调、循环IL-6升高。
- pre-ACLF患者还上调低密度中性粒细胞和粒细胞型髓源性抑制细胞相关基因,符合适应不良性EG。
- 基线适应不良性EG的出现与临床明显诱因的存在或性质无关。
- 在调整的时间-事件分析中,代表「中性粒细胞分化与免疫抑制」模块和「循环细胞」模块的eigengene升高各自独立与ACLF发展风险增高相关。
关键数值与推荐
- 共分析1260例无ACLF的ADC患者,其中124例(9.8%)在28天内发展为ACLF。
- WGCNA识别出22个基因模块及其各自eigengene。
- 「中性粒细胞分化与免疫抑制」模块和「循环细胞」模块的eigengene升高各自独立与ACLF发展风险增高相关(调整时间-事件分析)。
临床怎么用
- 入院时全血转录组特征可识别无ACLF的ADC患者中28天内ACLF高风险者。
- 中性粒细胞-粒细胞生成 perturbation 可能为靶向生物治疗提供方向。
- 这些发现有助于开发ACLF发展的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Whether whole-blood transcriptome analysis at admission in patients with acutely decompensated cirrhosis (ADC) without acute-on-chronic liver failure (ACLF) can uncover immune cell perturbations that characterize individuals who will subsequently develop ACLF is unknown. We aimed to investigate this question. METHODS: We analyzed whole-blood RNA-sequencing (RNA-seq) data obtained at admission (baseline) in 1,260 patients with ADC without ACLF. The outcome was ACLF development by day 28. RESULTS: A total of 124 patients (9.8%) developed ACLF and were considered to have pre-ACLF at admission. Compared with patients without pre-ACLF, those with pre-ACLF showed features of activated emergency granulopoiesis (EG), including neutrophilia, upregulation of the STAT3 gene and its downstream target CEBPB (encoding a master transcription factor driving EG), upregulation of genes related to immature and mature neutrophils, and elevated circulating interleukin-6, an activator of the STAT3-CEBPB axis. Patients with pre-ACLF also exhibited upregulation of genes associated with low-density neutrophils and granulocytic myeloid-derived suppressor cells, both known to suppress lymphocyte functions - features consistent with maladaptive EG. Baseline maladaptive EG was observed irrespective of the presence or nature of clinically apparent precipitants. Using weighted gene co-expression network analysis, we identified 22 gene modules and their respective eigengenes. In adjusted time-to-event analyses, increases in the eigengenes representing the "neutrophil differentiation & immunosuppression" module and the "cycling cells" module were each independently associated with higher risk of developing ACLF. Additionally, a higher proportion of patients with pre-ACLF developed new infections during hospitalization than those without pre-ACLF. CONCLUSIONS: Whole-blood transcriptomic profiling at admission in patients with ADC without ACLF revealed activation of maladaptive EG in those who subsequently developed ACLF within 28 days. IMPACT AND IMPLICATIONS: This study reveals that among patients who present for acutely decompensated cirrhosis without acute-on-chronic liver failure (ACLF), those who exhibit blood transcriptomic features of maladaptive emergency granulopoiesis are at high risk of developing ACLF by 28 days and of dying by 90 days. These results strongly suggest that neutrophil-granulopoietic perturbations play a pathogenic role in the development of poor outcomes. These results should lead to the development of biological therapies targeting neutrophil-granulopoietic perturbations, which is an unmet need. These findings should also give rise to the identification of potential biomarkers for ACLF development - another unmet need, as previous studies, particularly those relying on clinical blood counts, have failed to accurately predict this outcome.
引用
- Aguilar F, Lozano JJ, Clària J, et al. Maladaptive emergency granulopoiesis predicts poor outcomes in patients hospitalized with decompensated cirrhosis. J Hepatol. 2025. PMID: 41314350. doi:10.1016/j.jhep.2025.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。